NSE filing, NSE: RCF. Summary written from the filing by ALFA Finder's alert engine.
Rashtriya Chemicals & Fertilizers Ltd: key numbers
- Share price
- ₹101.35
- Market cap
- ₹5,591 Cr
- Revenue (annual)
- ₹18,480 Cr
- Net profit (annual)
- ₹427.4 Cr
- P/E (TTM)
- 12.5×Sector 20.8×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 1.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rashtriya Chemicals & Fertilizers Ltd
All →Rashtriya Chemicals & Fertilizers Board Meeting Date
Rashtriya Chemicals and Fertilizers Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. Trading window closes from 1 October 2026 to 14 November 2026.
Rashtriya Chemicals & Fertilizers Other Announcement
Rashtriya Chemicals and Fertilizers Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI LODR regulations.
Rashtriya Chemicals & Fertilizers Credit Rating
CARE Ratings reaffirmed RCF's Commercial Paper rating at CARE A1+ for a Rs.3000 Crore facility. The reaffirmation reflects stable capital structure and strong government-backed liquidity.
Rashtriya Chemicals & Fertilizers Debt & Borrowing
Rashtriya Chemicals and Fertilizers disclosed details of its outstanding listed NCDs as of September 30, 2026, complying with SEBI's ISIN specifications for debt securities.
Rashtriya Chemicals & Fertilizers Annual General Meeting
RCF shareholders approved an amendment to the objects clause and a fundraise of up to ₹1,500 Crore via a Further Public Offering at the AGM.
- Value
- ₹1,500 Cr
Rashtriya Chemicals & Fertilizers Capacity Expansion: ₹797 Cr Investment
RCF approved a ₹797 Crore order to L&T for revamping its Ammonia plant in Thal to enhance efficiency and reduce energy consumption.
- Value
- ₹797.0 Cr
- Execution
- 36 months
Other business update announcements
All →Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.
Rajshree Sugars & Chemicals Business Update
Rajshree Sugars reported October 2026 operational data for its three sugar units. Sugar sales were 17,849 MT, with no cane crushed during the month.
Fino Payments Bank Business Update
Fino Payments Bank's October 2026 update showed deposits crossing Rs 3,000 Crore for the first time. Loan referral disbursals rose 316% year-on-year to Rs 301 Crore.
Ugar Sugar Works Business Update
Ugar Sugar Works has informed the exchanges that crushing for the 2026-27 season started at its Ugar Unit on 06 Nov 2026. Crushing will ramp up to full capacity over time.
Aarti Drugs Business Update
Aarti Drugs disclosed that the US FDA inspected its subsidiary Pinnacle Life Science's Baddi plant on 2-6 November 2026 and issued three Form 483 observations. The company states there is no financial or operational impact.
GSM Foils Business Update
GSM Foils Limited reported Net Sales of Rs. 14,63,47,636 for October 2026, with April-October cumulative sales of Rs. 1,59,69,98,607. The monthly sales update is filed under Regulation 30.
- Value
- ₹14.63 Cr